GlaxoSmithKline plc (LON:GSK) shot up 2.1% during trading on Monday . The company traded as high as GBX 1,525.50 ($20.23) and last traded at GBX 1,520.50 ($20.17). 6,298,473 shares were traded during mid-day trading, a decline of 8% from the average session volume of 6,814,230 shares. The stock had previously closed at GBX 1,488.50 ($19.74).

Several equities analysts have recently weighed in on the company. S&P Global set a GBX 1,500 ($19.90) price target on GlaxoSmithKline plc and gave the company a “sell” rating in a report on Tuesday, June 6th. Liberum Capital restated a “buy” rating and issued a GBX 1,900 ($25.20) price target on shares of GlaxoSmithKline plc in a research note on Tuesday, June 6th. Jefferies Group LLC lifted their price objective on GlaxoSmithKline plc from GBX 1,800 ($23.88) to GBX 1,900 ($25.20) and gave the stock a “buy” rating in a report on Friday, June 16th. UBS AG set a GBX 1,600 ($21.22) price objective on GlaxoSmithKline plc and gave the stock a “neutral” rating in a report on Friday, June 9th. Finally, Deutsche Bank AG reiterated a “hold” rating and set a GBX 1,720 ($22.81) price objective on shares of GlaxoSmithKline plc in a research report on Friday, June 30th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of GBX 1,698.52 ($22.53).

The stock has a 50 day moving average of GBX 1,495.07 and a 200 day moving average of GBX 1,594.46. The stock’s market cap is GBX 74.32 billion.

The company also recently declared a dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, August 10th will be given a dividend of GBX 19 ($0.25) per share. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.

In related news, insider Patrick Vallance bought 861 shares of the stock in a transaction dated Friday, July 14th. The stock was bought at an average cost of GBX 1,618 ($21.46) per share, with a total value of £13,930.98 ($18,478.55). Also, insider Manvinder Singh Banga purchased 2,267 shares of the company’s stock in a transaction dated Wednesday, July 26th. The shares were bought at an average price of GBX 1,599 ($21.21) per share, for a total transaction of £36,249.33 ($48,082.41). In the last ninety days, insiders acquired 3,152 shares of company stock valued at $5,055,023.

ILLEGAL ACTIVITY NOTICE: “GlaxoSmithKline plc (GSK) Stock Price Up 2.1%” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.